Startseite Crystal structure of 3-methyl-2-phenyl-1,8-naphthyridine, C15H12N2
Artikel Open Access

Crystal structure of 3-methyl-2-phenyl-1,8-naphthyridine, C15H12N2

  • Yuan Wen , Xin-Sheng Xiao und Guo-Kai Jia EMAIL logo
Veröffentlicht/Copyright: 7. August 2019

Abstract

C15H12N2, monoclinic, P21/c (no. 14), a = 7.323(4) Å, b = 6.975(3) Å, c = 22.411(11) Å, β = 93.195(5)°, V = 1143.0(10) Å3, Z = 4, Rgt(F) = 0.0457, wRref(F2) = 0.1324, T = 296(2) K.

CCDC no.: 1940917

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Source of material

Under N2 atmosphere, t-BuOK (50 mol%), Xantphos (3 mol%), Ru3(CO)12 (1 mol%), (2-aminopyridin-3-yl)methanol (0.5 mmol), and propiophenone (0.5 mmol) were introduced in a Schlenk tube (25 mL), successively. Then, the Schlenk tube was closed and the resulting mixture was stirred in t-amyl alcohol (1.0 mL) at 383 K for 5 h. When the reaction was completed (monitored by TLC), the mixture was cooled to room temperature, the reaction mixture was concentrated by removing the solvent under vacuum, and the residue was purified by preparative TLC on silica, eluting with petroleum ether (333–363 K): ethyl acetate (4:1, v/v) to give 3-methyl-2-phenyl-1,8-naphthyridine as a colourless blocks.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.28 × 0.24 × 0.22 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.08 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω
θmax, completeness:27.4°, >99%
N(hkl)measured, N(hkl)unique, Rint:12343, 2569, 0.042
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2075
N(param)refined:155
Programs:Bruker [1], SHELX [2], Olex2 [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
N10.81060(13)0.60304(13)0.09694(4)0.0393(3)
N20.68573(15)0.78064(15)0.01798(5)0.0480(3)
C11.0526(2)0.4692(2)0.30428(6)0.0540(4)
H11.0946560.4753510.3441650.065*
C21.11924(19)0.5951(2)0.26334(6)0.0529(4)
H21.2057050.6865730.2756850.063*
C31.05791(18)0.58562(18)0.20409(5)0.0446(3)
H31.1011890.6730680.1769170.054*
C40.93197(16)0.44665(16)0.18451(5)0.0379(3)
C50.87055(15)0.43850(16)0.12004(5)0.0361(3)
C60.75318(15)0.60854(16)0.03818(5)0.0376(3)
C70.62649(19)0.7893(2)−0.03841(6)0.0522(3)
H70.5786240.905328−0.0524470.063*
C80.63013(19)0.6363(2)−0.07897(6)0.0537(4)
H80.5875500.652134−0.1185390.064*
C90.69723(18)0.4646(2)−0.05923(5)0.0489(3)
H90.7010370.360759−0.0851750.059*
C100.76095(15)0.44558(17)0.00099(5)0.0395(3)
C110.82862(16)0.27386(18)0.02707(5)0.0421(3)
H110.8361390.1647190.0034960.050*
C120.88319(15)0.26472(16)0.08613(5)0.0392(3)
C130.95794(19)0.08056(18)0.11286(6)0.0521(4)
H13A0.8628600.0144560.1323230.078*
H13B1.0566420.1089150.1414920.078*
H13C1.0019400.0010260.0817850.078*
C140.86522(18)0.32221(19)0.22652(6)0.0484(3)
H140.7799380.2292460.2144390.058*
C150.9243(2)0.3350(2)0.28623(6)0.0549(4)
H150.8768600.2525740.3140640.066*

Experimental details

Hydrogen atoms were placed in their geometrically idealized positions and constrained to ride on their parent atoms.

Comment

Nitrogen-containing heterocycles are of great importance in the pharmaceutical and agrochemical industries. Functionalized, nitrogen-containing heterocycles constitute a widespread structural motif in biologically active compounds [4], [5]. In particular, 1,8-naphthyridines are common structural motifs in important compounds. Consequently, the selective construction of such compounds is of significant importance. As part of our continuous research interest in construction of N-heterocycles by hydrogen transfer strategy [6], [7], [8], we report here a one-pot facile synthesis of 3-methyl-2-phenyl-1,8-naphthyridine. The crystal structure of 3-methyl-2-phenyl-1,8-naphthyridine has not been reported until now. Herein the crystal structure of the title compound is described to enrich the related crystal structures of 3-methyl-2-phenyl-1,8-naphthyridine.

As in our previous study [9], [10], the compound, built up by the C15H12N2 molecules, has been synthesized. The single crystal structure verifies that all bond lengths are in normal ranges. As expected, the naphthyridinyl moiety and the phenyl group are not coplanar (cf. the figure).

Funding source: Hunan university of science and engineering

Award Identifier / Grant number: XNZW17C04

Award Identifier / Grant number: XNZW17C05

Funding source: The Planned Science and Technology Project of Hunan YongZhou, China

Award Identifier / Grant number: 2018ZD15

Funding statement: This work was supported by the construct program of applied characteristic discipline in Hunan University of Science and Engineering; the opening project of key laboratory of comprehensive utilization of advantage plants resources in Hunan south, Hunan university of science and engineering (No. XNZW17C04, XNZW17C05). The Planned Science and Technology Project of Hunan YongZhou, China (NO. 2018ZD15).

References

1. Bruker. APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, WI, USA (2009).Suche in Google Scholar

2. Sheldrick, G. M.: SHELXT-integrated space-group and crystal-structure determination. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053273314026370Suche in Google Scholar PubMed PubMed Central

3. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Suche in Google Scholar

4. Ohfune, Y.; Shinada, T.: Enantio- and diastereoselective construction of α,α-disubstituted α-amino acids for the synthesis of biologically active compounds. Eur. J. Org. Chem. 2005 (2005) 5127–5143.10.1002/ejoc.200500434Suche in Google Scholar

5. Chen, X.; Zhao, H.; Chen, C.; Jiang, F.; Zhang, M.: Hydrogen-transfer-mediated α-functionalization of 1,8-naphthyridines by a strategy overcoming the over-hydrogenation barrier. Angew. Chem. Int. Ed. 56 (2017) 14232–14236.10.1002/anie.201707702Suche in Google Scholar PubMed

6. Chen, X.; Zhao, H.; Chen, C.; Jiang, H.; Min Zhang, M.: Iridium-catalyzed dehydrogenative α-functionalization of (hetero)aryl-fused cyclic secondary amines with indoles. Org. Lett. 20 (2018) 1171–1174.10.1021/acs.orglett.8b00096Suche in Google Scholar PubMed

7. Chen, X.; Li, Y. B.; Chen, L.; Zhu, Z.; Li, B.; Huang, Y.; Zhang, M.: Synthesis of N-biheteroarenes via acceptorless dehydrogenative coupling of benzocyclic amines with indole derivatives. J. Org. Chem. 84 (2019) 3559–3565.10.1021/acs.joc.9b00200Suche in Google Scholar PubMed

8. Chen, X.; Zhao, H.; Chen, C.; Jiang, F.; Zhang, M.: Transfer hydrogenative para-selective aminoalkylation of aniline derivatives with N-heteroarenes via ruthenium/acid dual catalysis. Chem. Commun. 54 (2018) 9087–9090.10.1039/C8CC04233KSuche in Google Scholar PubMed

9. Li, Y.; Yang, Z.; Wang, Z.; Zhu, Z.; Chen, X.: Synthesis, crystal structure and antitumor activities of 1,2,3,4-tetrahydroquinoline-2,4-diyl (bisdiphenylphosphine oxide) derivatives. Chin. J. Struct. Chem. 38 (2019) 713–718.Suche in Google Scholar

10. Li, Y. B.; Chen, L.; Zhu, Z. Z.; Huang, Y. B.; Chen, X. W.: Crystal structure of 2-(4-chlorophenyl)-3-phenyl-1,8-naphthyridine, C20H13N2Cl. Z. Kristallogr. NCS 234 (2019) 179–180.10.1515/ncrs-2018-0275Suche in Google Scholar

Received: 2019-05-22
Accepted: 2019-07-16
Published Online: 2019-08-07
Published in Print: 2019-11-26

©2019 Yuan Wen et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Frontmatter
  2. Crystal structure of [aqua[2,2′-(1,2-phenylene)bis(1H-imidazole-4-carboxylato-5-carboxy)-κ4N3,N3,O4,O4] zinc(II)] monohydrate, C16H10N4O9Zn⋅H2O
  3. Crystal structure of ethyl 3-(4-methoxyphenyl)-5-methylcarbamoyl-1H-pyrazole-4-carboxylate, C15H17N3O4
  4. 7-(4-Fluorobenzylidene)-3-(4-fluorophenyl)-N-phenyl-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbothioamide–dimethylformamide (2/1), C27H23F2N3S, 0.5(C3H7NO)
  5. Crystal structure of 4,4′-(hydrazonomethylene)diphenol dihydrate, C13H16N2O4
  6. Crystal structure of 4-methoxyphenyl-3-phenylpropiolate, C16H12O3
  7. Crystal Structure of tris(tetrakis{1-vinyl-1H-imidazole-κN}copper(II)) bis[tri-μ2-bromido-tetrabromido-bis(1-vinyl-1H-imidazole-κN)tetracopper(I)], C80H96N32Cu11Br14
  8. Crystal structure of (E)-2-(3,6-bis(diethylamino)-9H-xanthen-9-yl)-N′-(quinoxalin-2-ylmethylene)benzohydrazide, C37H36N6O2
  9. Crystal structure of 4-(1-phenylimidazo[1,5-a]pyridin-3-yl)benzoic acid (C20H14N2O2)
  10. Crystal structure of 3-fluoro-3-methyl-1-((2-nitrophenyl)sulfonyl)-5,5-diphenylpiperidine, C24H23FN2O4S
  11. Crystal structure of dimethyl 3,12-dibenzyl-6,10-diphenyl-3,12-diazapentacyclo [6.3.1.02.7.04.11.05.9]-dodecane-7,11-dicarboxylate — acetone (2/1), C40H38N2O2 ⋅ 0.5C3H6O
  12. Crystal structure of poly[(μ2-2-(1H-1,2,4-triazol-1-yl)benzoato-κ4O:O′:N:N′)silver(I)] monohydrate, C9H8AgO3N3
  13. Crystal structure of poly[(μ2-9H-carbazole-3,6-dicarboxylate-κ4O1,O2:O3,O4)(μ2-1,3-di(pyridin-4-yl)propane-κ2N:N)cadmium(II)]monohydrate, C27H23N3O5Cd
  14. The synthesis and crystal structure of bis(2-(benzo[d]thiazol-2-yl)-5-methylbenzen-1-ido-κ2C,N)-(N,N′-diethyldithiocarbamato-κ2S,S′)iridium(III), C33H30N3S4Ir
  15. The crystal structure of 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(trifluoromethylsulfonyl)-1H-pyrazole-3-carboxamide, C12H6N4Cl2F6O3S
  16. Synthesis and crystal structure of poly[(μ2-nitrato-κ4O,O′:O′,O′′)-nitrato-κO-(μ2-1,4-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′)cadmium(II)], C14H14N6O6Cd
  17. Crystal structure of ethyl (Z)-(4-oxo-4-phenylbut-2-en-2-yl)glycinate, C14H17NO3
  18. Halogen bonds in the crystal structure of 5-bromo-3,4′-bipyridine – 1,4-diiodotetrafluorobenzene (2/1), C26H14Br2F4I2N4
  19. Crystal structure of bis(2,2′-bipyridine-κ2N,N′)-tetrakis(μ2-3-(phenylsulfonamido)propanoato-κ2O:O′)-bis(3-(phenylsulfonamido)propanoato-κ2O,O′)digadolinium(III) – 2,2′-bipyridine (1/1), C84H84Gd2N12O24S6
  20. Crystal structure of poly[aqua(μ2-2-amino-1,4-benzenedisulfonato-κ2O:O′)bis(μ2-pyrazin-κ2N:N′)silver(I)], C14H16Ag2N5O8S2
  21. The crystal structure of 1,6-di-tert-butyl-1,1,3,3,4,4,6,6-octamethyl-2,2,5,5-tetrakis (trimethylsilyl)hexasilane, C28H78Si10
  22. Crystal structure of discandium triruthenium tetrasilicide, Sc2Ru3Si4
  23. Crystal structure of poly[(μ2-4-amino-1,5-naphthalenedisulfonato-κ4O,N:O′, N′)bis(μ2-hexamethylenetetramino-κ2N;N′)silver(I)], {C22H30Ag2N9O6S2}n
  24. Crystal structure of diaqua[5,5′-dicarboxy-2,2′-(propane-1,3-diyl)bis(1H-imidazole-4-carboxylato-κ4O,O′,N,N′)]zinc(II) dihydrate, C13H18N4O12Zn
  25. The crystal structure of poly [(μ3-N1,N4-bis(pyridin-3-yl)cyclohexane-1,4-dicarboxamide-κ3-O:N:N′)-(p-toluenesulfonato-κ2O,O′)silver(I)], C25H27Ag1N4O5S
  26. The crystal structure of 1,2-bis(3-bromophenoxy) ethane, C14H12Br2O2
  27. The crystal structure of 4-(pyren-1-yl)butyl-3-nitrobenzoate, C27H21NO4
  28. Crystal structure of bis[(2-(4-chlorophenyl)-5-methyl-1,3-dioxane-5-carboxylato-κ1O) (5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II), C40H60Cl2N4NiO8
  29. The crystal structure of 1,5-dinitro-2,3,4-trichlorobenzene, C6H1Cl3N2O4
  30. The crystal structure of the solid solution of 3,5-dinitropyrazole and 4-chlorine-3,5-dinitropyrazole, C3H1.24Cl0.76N4O4
  31. The cocrystal structure of 4-nitropyrazole — acetic acid (1/1), C5H7N3O4
  32. The crystal structure of propan-2-one O-(2,4,6-trinitrophenyl) oxime, C9H8N4O7
  33. The crystal structure of ethyl 2-(3-(2-ethoxy-2-oxoethyl)benzo[d] thiazol-2(3H)-ylidene)acetate, C15H17NO4S
  34. Crystal structure of (acetic acid-κ1O)-bis(μ2-2-chlorobenzoato-κ2O:O′)-(2-chlorobenzoato-κ1O)-(μ2-hydroxy-κ2O:O)-bis(1,10-phenanthroline-κ2N,N′)dimanganese(II) — methanol (1/1), C48H37Cl3Mn2N4O10
  35. Crystal structure of 3-methyl-2-phenyl-1,8-naphthyridine, C15H12N2
  36. Crystal structure of chlorido-(5-acetyl-2-(5-methylpyridin-2-yl)benzen-1-ido-κ2C,N)-pyridine-κN-palladium(II), C19H17ClN2OPd
  37. Crystal structure of (4-methyl-benzoato-κ2O,O′)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) perchlorate monohydrate, C24H45ClN4NiO7
  38. Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6) 1,2,3,4,5-pentamethyl-cyclopenta-2,4-dien-1-yl(potassium, rubidium) — ammonia (1/2), [K0.3Rb0.7(18-crown-6)]Cp*⋅2 NH3, C22H45K0.3N2O6Rb0.7
  39. Crystal structure of (3E,5E)-1-((4-fluorophenyl)sulfonyl)-3,5-bis(3-nitrobenzylidene)piperidin-4-one — dichloromethane (2/1), C51H38Cl2F2N6O14S2
  40. Crystal structure of (E)-N′-((1,6-dihydropyren-1-yl)methylene)isonicotinohydrazide — methanol (1/1), C24H19N3O2
  41. Crystal structure of poly[aqua(μ2-2-amino-1,4-benzenedisulfonato-κ3N,O:O′)-(μ4-hexamethylenetetramino-κ4N:N′:N′′:N′′′)disilver(I)] monohydrate, C12H21Ag2N5O8S2
  42. Crystal structure of bis(acridin-10-ium) 2,5-dihydroxyterephthalate — 2,5-dihydroxyterephthalic acid (1/1), C21H15NO6
  43. The crystal structure of 1,12-diazaperylene, C18H10N2
  44. Crystal structure of 1-(5-(4-chlorophenyl)-3-(2-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethan-1-one, C17H14N2OFCl
  45. Crystal structure of (4aR,6aR,6bR,10S,12aR)-10-acetoxy-1,2,3,4, 4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a, 12b,13,14b-icosahydro-2,2,4a,6b,9,9,12a-heptamethylpicene-6a-carboxylic acid, C32H50O4
  46. The crystal structure of tetrachlorido-bis{1,3-bis(2,6-diisopropylphenyl)-1H-3λ4-imidazol-2-yl}-(μ2-pyrimidine-κ2N:N′)dipalladium(IV) — dichloromethane (1/2), C60H80Cl8N6Pd2
  47. The crystal structure of (E)-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbut-2-en-1-yl 4-nitrobenzoate, C22H19NO7
  48. Crystal structure of 3-methyl-N-(pyrimidin-5-ylmethyl)pyridin-2-amine, C11H12N4
  49. The crystal structure of 2,5-dichloroterephthalic acid dihydrate, C8H8Cl2O6
  50. The crystal structure of 2,4,6-tris[4-(1H-imidazol-1-yl)phenyl]-1,3,5-triazine — dimethylformamide (1/1), C33H28N10O
  51. Crystal structure of N-(adamantan-1-yl)-5-(dimethylamino)naphthalene-1-sulfonamide, C22H28N2O2S
  52. Crystal structure of poly[diaqua-(μ4-4-(3,5-dicarboxy-κ1O-phenoxy)phthalato-κ3O:O′:O′)cadmium(II)], C16H12CdO11
  53. Crystal structure of poly[diaqua-bis(μ2-3-((1H-imidazol-1-yl)methyl)benzoato-κ2N:O)manganese(II)], C22H22MnN4O6
  54. Crystal structure of 9-(3-phenoxyphenyl)-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione, C25H23NO3
  55. The crystal structure of poly[(μ3-2,4,6-tris[4-(1H-imidazol-1-yl)phenyl]-1,3,5-triazine-k3N:N′:N′′)-(nitrato-k2O,O)-(nitrato-k1O)zinc(II)] - N,N-dimethylacetamide (1/2), C38H39N13O8Zn
  56. Crystal structure of poly[(μ7-4-(3,5-dicarboxylatophenoxy)phthalato)-(1,10-phenanthroline-κ2N,N′)dizinc(II)], C28H14N2O9Zn2
  57. The crystal structure of methyl 2-(benzylamino)-5-(benzyloxy)benzoate, C22H21NO3
  58. Crystal structure of (1,4,8,11-tetraazacyclotetradecane)palladium(II) tetracyanoplatinate(II), C14H24N8PdPt
  59. Crystal structure of (pyridine-2-carboxylato-κ2N,O)-[2-(2-pyridyl)phenyl-κ2N,C1]palladium(II), C17H12N2O2Pd
  60. Crystal structure of (cyclohexane-1,4-diammonium) 4-[(4-carboxylatophenyl)disulfanyl]benzoate dimethylsulphoxide hydrate (1/1/1/1), [C6H16N2]2+[C14H8O4S2]2−⋅C2H6OS⋅H2O
  61. Crystal structure of the 2:1 co-crystal 2-[(2-carboxyphenyl)disulfanyl]benzoic acid – 3-bromobenzoic acid, 2(C14H10O4S2)⋅C7H5BrO2
  62. Crystal structure of chlorido-dimethyl-(phenylpiperazine-1-carbodithioato-κ2S,S′)tin(IV), C13H19ClN2S2Sn
  63. Crystal structure of (N-n-butyl, N-methyl-dithiocarbamato-κ2 S,S′)-chlorido-dimethyl-tin(IV), C8H18ClNS2Sn
  64. Crystal structure of (2,2′-bipyridyl)bis(4-bromobenzyl)dibromidotin(IV), C24H20Br4N2Sn
  65. Crystal structure of (2,2′-bipyridyl)bis(4-chlorobenzyl)dichloridotin(IV), C24H20Cl4N2Sn
  66. Crystal structure of N-methyl-N-phenyl(methylsulfanyl)carbothioamide, C9H11NS2
  67. Crystal structure of 4-phenylpiperazin-1-ium (4-phenylpiperazin-1-yl)carbothioylsulfanide, [C10H15N2][C11H13N2S2]
  68. Crystal structure of catena-{di-aqua-sodium [n-butyl(methyl)carbamothioyl]sulfanide}n, [C6H16NNaO2S2]n
  69. Crystal structure of (2-([1,1-bis(hydroxymethyl)-2-oxyethyl]iminomethyl)-5-(n-decyl)phenolato)-dimethyl-tin(IV), C23H39NO5Sn
  70. Crystal structure of 4-chloro-N′-[(1E)-(3-ethoxy-2-hydroxyphenyl)methylidene]benzohydrazide – a Z′ = 3 structure, C16H15ClN2O3
Heruntergeladen am 17.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0364/html
Button zum nach oben scrollen